Emerging innovations and non-antibiotic approaches to address urgent need to control infectious diseases, including multiple-drug resistant ‘super-bugs’
Richard Pilnik has been appointed president of Innovex, a Quintiles company that provides product lifecycle management services to pharmaceutical and biotech companies.